Skip to main content

Peer Review reports

From: BYL719 reverses gefitinib-resistance induced by PI3K/AKT activation in non-small cell lung cancer cells

Original Submission
5 May 2023 Submitted Original manuscript
22 May 2023 Author responded Author comments - Yanjuan Zhu
29 May 2023 Author responded Author comments - Yanjuan Zhu
Resubmission - Version 2
22 May 2023 Submitted Manuscript version 2
7 Jul 2023 Reviewed Reviewer Report
10 Jul 2023 Reviewed Reviewer Report
24 Jul 2023 Author responded Author comments - Yanjuan Zhu
Resubmission - Version 3
24 Jul 2023 Submitted Manuscript version 3
26 Jul 2023 Author responded Author comments - Yanjuan Zhu
Resubmission - Version 4
26 Jul 2023 Submitted Manuscript version 4
Publishing
31 Jul 2023 Editorially accepted
8 Aug 2023 Article published 10.1186/s12885-023-11243-0

You can find further information about peer review here.

Back to article page